Eating Disorder Prevention Program for Type 1 Diabetes
Trial Summary
What is the purpose of this trial?
This study aims to test the effectiveness of an evidence-based eating-disorder prevention program specifically targeted for individuals with Type 1 Diabetes (T1D) compared to an educational control group. The Diabetes Body Project (DBP), is an adaptation of the Body Project which is the only eating disorder prevention program to have repeatedly produced effects when evaluated by independent researchers, produced stronger effects than credible alternative interventions, and affected objective outcomes. DBP has been adapted slightly for individuals with T1D who are at ultra-high risk for eating disorders. The study aims to test the effectiveness of the DBP of reducing body image concerns and reducing eating pathology and improving glycemic control.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, since participants must be using insulin, it seems you will need to continue with your insulin treatment.
What data supports the effectiveness of the Diabetes Body Project treatment for preventing eating disorders in young women with type 1 diabetes?
Is the Eating Disorder Prevention Program for Type 1 Diabetes safe for humans?
The research does not specifically mention safety concerns for the Eating Disorder Prevention Program, but it is based on the Body Project, which is a well-established program for preventing eating disorders. Generally, such programs are considered safe as they focus on education and behavior change.14567
How is the Diabetes Body Project treatment different from other treatments for eating disorders in type 1 diabetes?
The Diabetes Body Project is unique because it is a virtual program specifically adapted to prevent eating disorders in young women with type 1 diabetes, focusing on reducing risk factors and symptoms through a tailored approach, unlike standard treatments which often have poorer outcomes in this group.13489
Research Team
Line Wisting, PhD
Principal Investigator
Oslo University Hospital
Eric Stice, PhD
Principal Investigator
Stanford University
Elena Toschi, MD
Principal Investigator
Joslin Diabetes Center
Maartje de Wit, PhD
Principal Investigator
Amsterdam Medical University Centers
Eligibility Criteria
This trial is for individuals aged 14-35 with Type 1 Diabetes (T1D) who have been diagnosed for at least a year, are using insulin, and have some body image concerns. It's not suitable for those without these concerns, with less than a year's diagnosis of T1D, or who've had recent severe eating disorder treatment.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the Diabetes Body Project (DBP) or an educational control program
Follow-up
Participants are monitored for changes in body image, eating pathology, and glycemic control
Treatment Details
Interventions
- Diabetes Body Project
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oslo University Hospital
Lead Sponsor
Stanford University
Collaborator
Joslin Diabetes Center
Collaborator
Amsterdam UMC, location VUmc
Collaborator
Juvenile Diabetes Research Foundation
Collaborator
University of Minnesota
Collaborator